November 13, 2024 at 10:07 am

BioStem Puts Its Best Foot Forward, Achieving Third Sequential Quarter of Record Growth

The MedTech company BioStem Technologies, Inc. (BSEM) known for its focus on developing, manufacturing, and commercializing placental-derived biologics has reported its third quarter earnings which also marks its third sequential quarter of record growth. BioStem’s revenue for the first nine months of 2024 totals almost $200M, $82.6M of which has come from its third quarter…. [Read More]
November 12, 2024 at 2:27 pm

Stocks making the biggest moves midday: Shopify, Honeywell, GE Vernova, Twilio and more

Here’s a round-up of the companies drawing attention in midday trading. Shopify made waves as shares skyrocketed by 26%, following the announcement of a third-quarter operating income of $283 million – a significant increase from last year’s $122 million. Their revenue of $2.16 billion also exceeded predicted estimates, making it a record-breaking day for the… [Read More]
November 12, 2024 at 10:24 am

Charged Up Cherries and Berries: Beam Launches the BeamPatrol Electric Motorcycle for Law Enforcement

PRISM Emerging EV Index company Beam Global (BEEM), a leader in sustainable infrastructure solutions for transportation electrification and energy security, has officially launched the BeamPatrol™ law enforcement electric motorcycle and charging bundle. This off-grid charging station offers a turnkey solution powered entirely by renewable energy, featuring four chargers and four high-performance electric motorcycles from Zero… [Read More]
November 12, 2024 at 10:13 am

Actuate Wins FDA Rare Pediatric Disease Designation for Ewing Sarcoma Treatment

Actuate Therapeutics, Inc. (NASDAQ: ACTU) has received FDA rare pediatric disease designation for elraglusib, a GSK-3β inhibitor, for treating Ewing sarcoma (EWS). EWS is a highly metastatic bone sarcoma, most prevalent in children and adolescents, with limited effective treatments. The company’s ongoing Phase 1/2 trial of elraglusib in relapsed/refractory EWS is actively enrolling, with topline… [Read More]
November 12, 2024 at 9:33 am

Stocks making the biggest moves premarket: Shopify, Home Depot, Live Nation Entertainment and more

Here are the businesses that are creating a buzz in the market before the opening bell. Shopify — This operator in the e-commerce platform industry saw a 14% surge after declaring its third-quarter operational income at $283 million, a significant leap from $122 million from 2020’s same period. Shopify’s revenue, at $2.16 billion, exceeded FactSet’s… [Read More]
November 12, 2024 at 8:50 am

Aethlon Medical Begins Hemopurifier® Cancer Trial in Australia with First Patient Enrollment

Aethlon Medical, Inc. (Nasdaq: AEMD) has enrolled the first patient in its Australian safety, feasibility, and dose-finding trial of the Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti-PD-1 therapy with pembrolizumab (Keytruda®) or nivolumab (Opdivo®). Conducted at the Cancer Clinical Trials Unit at CALHN, Royal Adelaide Hospital, this trial… [Read More]
November 11, 2024 at 2:10 pm

Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more

Here’s an overview of the companies grabbing headlines in the midday trading territory: Tesla — Witnesses a 7% surge, adding to last week’s 29% spike as market participants speculate that the upcoming Trump administration could benefit the business and its CEO, Elon Musk. AbbVie — stock decreased by 12% after the drug-maker revealed its experimental… [Read More]